当前位置:首页 - 行情中心 - 康惠制药(603139) - 财务分析

康惠制药

(603139)

  

流通市值:19.38亿  总市值:19.38亿
流通股本:9988.00万   总股本:9988.00万

康惠制药(603139)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润-0.27亿元,每股收益-0.17元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益87944.82万元,未分配利润26051.62万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产191779.97万元,负债103835.15万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入121,353,198.96561,634,852.83404,545,531.96265,668,337.76
营业总成本150,382,034.67637,858,647.3455,454,003.35288,768,212.05
营业利润-27,289,895.68-122,990,871.52-45,979,749.33-9,349,685.52
利润总额-27,259,620.59-121,540,375.86-46,254,180.52-9,881,795.06
净利润-27,456,184.89-111,997,348.65-47,782,213.85-17,108,394.22
其他综合收益--2,407,316.57--
综合收益总额-27,456,184.89-114,404,665.22-47,782,213.85-17,108,394.22
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计644,265,630.42598,970,093.42726,429,924.79759,592,226.77
非流动资产合计1,273,534,060.561,288,871,786.921,280,774,629.631,279,296,223.26
资产总计1,917,799,690.981,887,841,880.342,007,204,554.412,038,888,450.03
流动负债合计677,248,063.78598,249,355.35616,467,447.03609,124,604.23
非流动负债合计361,103,424.72382,688,137.62416,384,994.09426,451,488.18
负债合计1,038,351,488.5980,937,492.971,032,852,441.121,035,576,092.4
归属于母公司股东权益合计840,082,845.88857,322,192.02910,945,439.71940,531,904.65
股东权益合计879,448,202.49906,904,387.37974,352,113.291,003,312,357.63
负债和股东权益合计1,917,799,690.981,887,841,880.342,007,204,554.412,038,888,450.03
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计124,403,140.61614,413,295.84460,121,083.94323,123,252.23
经营活动现金流出小计140,970,914.69577,119,124.42495,159,067.46337,423,930.61
经营活动产生的现金流量净额-16,567,774.0837,294,171.42-35,037,983.52-14,300,678.38
投资活动现金流入小计738,109.0363,158,610.8650,350,737.6646,674,114.1
投资活动现金流出小计6,083,635.9379,682,556.12113,315,619.8844,626,340.96
投资活动产生的现金流量净额-5,345,526.9-16,523,945.26-62,964,882.222,047,773.14
筹资活动现金流入小计70,428,932.28347,555,973.03351,117,999.19278,896,123.79
筹资活动现金流出小计41,196,410.11413,546,553.88289,523,091.7237,715,868.16
筹资活动产生的现金流量净额29,232,522.17-65,990,580.8561,594,907.4941,180,255.63
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额7,319,221.19-45,220,354.69-36,407,958.2528,927,350.39
期末现金及现金等价物余额104,918,488.3697,599,267.17113,435,205.75171,746,972.25
TOP↑